Advanced search
Publication Cover
Hypertension in Pregnancy Volume 35, 2016 - Issue 2
Submit an article Journal homepage
766
Views
42
CrossRef citations to date
0
Altmetric
Research Article

Efficacy of L-arginine for preventing preeclampsia in high-risk pregnancies: A double-blind, randomized, clinical trial

E. E. Camarena Pulidoa Unidad de Investigación División de Ginecología y Obstetricia, Hospital Civil de Guadalajara “Dr. Juan I. Menchaca”, Guadalajara, Jalisco, Mexico
,
L. García Benavidesb INTEC, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Jalisco, MexicoCorrespondence[email protected]
,
J. G. Panduro Baróna Unidad de Investigación División de Ginecología y Obstetricia, Hospital Civil de Guadalajara “Dr. Juan I. Menchaca”, Guadalajara, Jalisco, Mexico
,
S. Pascoe Gonzalezb INTEC, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Jalisco, Mexico
,
A. J. Madrigal Saraya Unidad de Investigación División de Ginecología y Obstetricia, Hospital Civil de Guadalajara “Dr. Juan I. Menchaca”, Guadalajara, Jalisco, Mexico
,
F. E. García Padillaa Unidad de Investigación División de Ginecología y Obstetricia, Hospital Civil de Guadalajara “Dr. Juan I. Menchaca”, Guadalajara, Jalisco, Mexico
&
S. E. Totsuka Suttob INTEC, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Jalisco, Mexico
 show all
Pages 217-225 | Received 17 Jul 2015, Accepted 17 Dec 2015, Published online: 22 Mar 2016

References

  • Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102:181–192.
  • Bilano VL, Ota E, Ganchimeg T, Mori R, Souza JP. Risk factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middle-income countries: a WHO secondary analysis. PLoS One 2014;9(3):e91198. doi:10.1371/journal.pone.0091198.
  • Jjankowski M. Angiogenesis inhibition and preeclampsia. J Hypertens. 2009;27:707–708.
  • Lyall F, Greer IA. The vascular endothelium in normal pregnancy and preeclampsia. Rev Reprod. 1996;1(2):107–116.
  • Valdes G, Kaufmann P, Corthorn J, Erices R, Brosnihan KB, Joyner-Grantham J. Vasodilator factors in the systemic and the local adaptations to pregnancy. Biol Endoc Rep. 2009;7:79.
  • Seligman SP, Buyon JP. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol. 1994;17:944–948.
  • Sauvidou MD, Hingorani AD, Tsikas D, Frolich JC, Vallance P, Nicolaides KH. Endothelial dysfunction and raised plasma concentration of asymmetric dimetylarginine in pregnant women who subsequently developed preeclampsia. Lancet. 2003;361:1511–1517.
  • Boger RH, Diemert A. The role of nitric oxide synthase inhibition by asymmetric dimethylarginine in the pathophysiology of preeclampsia. Gynecol Obstet Invest. 2009;69(1):1–13.
  • Kim YJ, Park HS. Reduced L arginine level and decreased placental eNOS activity in preeclampsia. Placenta. 2006;27(4–5):438–444.
  • Laskowska M, Laskowska K, Leszczyńska-Gorzelak B, Oleszczuk J. Asymmetric dimethylarginine in normotensive pregnant women with isolated fetal intrauterine growth restriction: a comparison with preeclamptic women with and without intrauterine growth restriction. J Matern Fetal Neonatal Med. 2011;24(7):936–942.
  • Boger RH, Bode-Boger SM. The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol. 2001;41:79–99.
  • Boger RH. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase explains the “L arginine paradox” and acts as a novel cardiovascular risk factor. J Nutri. 2004;134:2842–2847.
  • Neri I, Jasoni VM, Gori GF, Blasi I, Fachinnetti F. Effect of L-arginine on blood pressure in pregnancy-induced hypertension: a randomized placebo-controlled trial. J Matern Fetal Neonatal Med. 2006;19(5):277–281.
  • Rytlewski K, Olszanecki R, Korbut R, Zdebski Z. Effects of prolonged oral supplementation with L-arginine on blood pressure and nitric oxide synthesis in preeclampsia. Eur J Clin Invest. 2005;35:32–37.
  • Duckitt K, Harrington D. Risk factors for preeclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;10:1136.
  • ACOG Diagnosis and management of preeclampsia and eclampsia. Practice Bulletin 33; 2002.
  • Vadillo-Ortega F, Perichart-Perera O, Espino S, et al. Effect of supplementation during pregnancy with L arginine and antioxidant vitamins in medical food on preeclampsia in high risk population: randomized controlled trial. BMJ. 2011;342:d2901.
  • Facchinetti F, Saade GR, Neri I, Pizzi C, Longo M. L arginine supplementation in patients with gestational hypertension in pregnancy. Hypertens Pregn. 2007;26(1):121–130.
  • Rytlewski K. Effects of oral l arginine on the fetal condition and neonatal outcome in preeclampsia. Preliminary report. Pharmacol Toxicol. 2006;99(2):146–152.
  • Hjarturdottir S, Leifsson BG, Steinthorsdottir V. Recurrence of hypertensive disorder in second pregnancy. Am J Obstet Gynecol. 2006;194(4):916–920.
  • Shim SS, Lee CH, Jun JK. Midtrimester maternal plasma concentrations of angiopoietin 1, angiopoietin 2, and placental growth factor in pregnant women who subsequently develop preeclampsia. Obstet Gynecol Sci. 2015;58(1):10–16. doi:10.5468/ogs.2015.58.1.10.
  • Noris M, Todeshini M, Cassis P, et al. L arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension. 2004;43:614–622.
  • Böger Rainer H, Ron Eyal S. L-arginine improves vascular function by overcoming the deleterious effects of ADMA, a novel cardiovascular risk factor. Altern Med Rev. 2005;10(1):14–23.
  • Blum A, Porat R, Rosenschein U, et al. Clinical and inflammatory effects of dietary L-arginine in patients with intractable angina pectoris. Am J Cardiol. 1999;83:1488–1490.
  • Ceremuzynski L, Chamiec T, Herbaczynska-Cedro K. Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris. Am J Cardiol. 1997;80:331–333.
  • Bujold E, Roberge S, Lacasse Y, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010;116(2Pt1):402–414. doi:10.1097/AOG.0b013e3181e9322a.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.